Logo: IDIBELL -Institut d'Investigació Biomèdica de Bellvitge-

 
Web   People
 You are at: Home > Clinical Research Ethics Committee (CEIC)
Clinical Research Ethics Committee (CEIC)

Composition of the CEIC


On 31st December 2005, the CEIC was made up of the following members:

President:
Dr. Pablo Ferrer Salvans
Clinical Pharmacology

Secretary:
Dr. Mª Ignacia Ferrer Salvans*
Pharmacy

Board members:
Dr. Josep Mª Argimón Pallars
CatSalut (independent member)

Dr. Javier Avila Pérez de Bustos
Intensive Medicine

Dr. Pedro Fernández Viladrich
Infectious diseases

Dr. Margarita García Martín
Medical Oncology

Dr. Francisco Moreso Mateos
Nephrology

Dr. Francisco Rubio Borrego
Neurology

Dr. Carlos Villabona Artero
Endocrinology

 

Dr Ramon Jódar Masanés*
Pharmacy


Ms. Mª Eulalia Juvé Udina
Nursing

Ms. Cristina Matud Calvo
Nursing

Ms. Rosa Solá Herrera
Nursing

Ms. Consol Felip Farras
Lay member

Mr. Xavier Ribalta Balcells
Lawyer

Ms. Gloria Gálvez Hernando
User care

*Since March 2006, the secretary has been Dr Ramon Jódar Masanés

 


 


Summary of the CEIC's activity during 2005


The Clinical Research Ethics Committee met 21 times during 2005, a year when 353 clinical research proposals were put forward for evaluation, representing an increase of 19% on the previous year, with 57 more proposals.

This increase goes up to 110% if we compare it with 2001, at the beginning of the latest five-year period, with the presentation of 185 more proposals in 2005.

Graph 1 summarises the development of the proposals presented to CEIC, according to the type of clinical study, over the last five years, showing the growth of the total number of proposals, clinical trials and other research projects in 2005.

The greatest growth has occurred in genetic research projects, which have jumped from 52 to 109, an increase of 110%.



Development of proposals for clinical trials with drugs,
other research projects and the total number of proposals presented to the CEIC


Clinical research proposals presented to the CEIC: distribution by type of promoter


Firstly, it must be said that in 2005 the number of clinical trials and observational studies promoted by the pharmaceutical industry has grown once again - 10% compared to 2004, reaching a figure of 121.

The number of studies on the initiative of the CSUB's medical services has also grown, with a total of 160 projects - that is, 20 more than in 2004 (+14%).

Of the centres making up IDIBELL, the greatest increase is in projects promoted by the Oncological Research Institute (IRO), which has grown by 128%.



Distribution of research proposals by centres: year 2005



Results of the CEIC assessment of clinical research proposals for 2005


During 2005, 366 proposals were evaluated by the CEIC (25% more than in the previous year):

11 proposals from 2004 which were awaiting evaluation
9 from previous years which this year have been evaluated for other centres or, in the case of research projects, for other grant award rounds
346 of the proposals presented in 2005


The following graph shows, as a percentage, the final results of CEIC's evaluation of clinical research proposals in 2005.


Up
© Institut d'Investigació Biomèdica de Bellvitge